Cargando…
Reporting practices of pharmacodynamic studies involving invasive research procedures in cancer trials
BACKGROUND: Tumour biopsy for pharmacodynamic (PD) study is increasingly common in early-phase cancer trials. As they are non-diagnostic, the ethical justification for such procedures rests on their knowledge value. On the premise that knowledge value is related to reporting practices and outcome di...
Autores principales: | Freeman, G A, Kimmelman, J, Dancey, J, Monzon, J G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749582/ https://www.ncbi.nlm.nih.gov/pubmed/23887602 http://dx.doi.org/10.1038/bjc.2013.417 |
Ejemplares similares
-
A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas
por: Duran, I, et al.
Publicado: (2006) -
A trial of consent procedures for future research with clinically derived biological samples
por: Vermeulen, E, et al.
Publicado: (2009) -
Clinical pharmacodynamic factors in docetaxel toxicity
por: Puisset, F, et al.
Publicado: (2007) -
Chlorambucil and lomustine (CL56) in absolute hormone refractory prostate cancer: re-induction of endocrine sensitivity an unexpected finding
por: Shamash, J, et al.
Publicado: (2005) -
Pharmacodynamics Must Inform Statistics: An Example from a Cocaine Dependence Pharmacotherapy Trial
por: Winhusen, Theresa M., et al.
Publicado: (2014)